AI-powered search
Try Polaris, our new AI-powered search!

What impact does ritlecitinib’s dual inhibition of JAK and TEC pathways have on the immune response in alopecia areata?

Featuring Glynis Ablon, MD |

Associate Clinical Professor 
University of California, Los Angeles
Ablon Skin Institute & Research Center
Los Angeles, CA

| Published December 02, 2024